Exelixis | 销售和管理费用

Selling And Administration Expenses 更改 日
Acadia Pharmaceuticals USD 107.99M 3.47M 2024-03
Amgen USD 1.81B 44M 2024-03
AstraZeneca USD 3.91B 194M 2023-09
Bayer EUR 3.83B 234M 2024-03
BioMarin Pharmaceutical USD 225.91M 49.12M 2024-03
Bristol-Myers Squibb USD 2.37B 303M 2024-03
Cytokinetics USD 45.5M 1.39M 2024-03
Eisai JPY 92.17B 616M 2023-12
Eli Lilly USD 1.84B 88.5M 2024-03
Exelixis USD 113.98M 24.16M 2024-03
Genmab DKK 839M 9M 2023-09
Incyte USD 300.3M 6.44M 2024-03
Ionis Pharmaceuticals USD 52.64M 18.37M 2024-03
Merck USD 2.48B 268M 2024-03
Moderna USD 274M 196M 2024-03
Neurocrine Biosciences USD 243.1M 38.9M 2024-03
Pfizer USD 3.5B 976M 2024-03
Takeda JPY 267.52B 14.57B 2023-12
Ultragenyx Pharmaceutical USD 78.16M 1.33M 2024-03



Exelixis 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.